CSIMarket
 

Motus Gi Holdings Inc   (MOTS)

Motus Gi Holdings Inc 's

Competitiveness




 

MOTS Sales vs. its Competitors Q1 2024



Comparing the current results to its competitors, Motus Gi Holdings Inc reported Revenue increase in the 1 quarter 2024 by 14.29 % year on year.
The sales growth was above Motus Gi Holdings Inc 's competitors' average revenue growth of 3.92 %, achieved in the same quarter.

List of MOTS Competitors





Revenue Growth Comparisons




Net Income Comparison


Motus Gi Holdings Inc , slower than the average decrease reported by the company's competitors of -23.85 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -23.85 %

<<  MOTS Stock Performance Comparisons


Motus Gi Holdings Inc 's Comment on Competition and Industry Peers


The company identifies no direct competitors utilizing technology similar to its own. Major manufacturers in the U.S. colonoscope market include Olympus Corp, Pentax Medical, and Fujifilm Medical. Smaller equipment providers such as Medivators and Erbe offer lower-powered irrigation pumps. Medjet Ltd. is developing an intra-procedural device for spot cleaning through the working channel of a scope, but it does not provide full colon cleaning capability. Additional companies selling ancillary devices and accessories include Boston Scientific, Medtronic GI Solutions, Conmed Corporation, Steris, and Ambu A/S. These established competitors possess greater resources and may develop new devices that could make the company's Pure-Vu System obsolete or uneconomical. Alternative technologies in colon cancer screening include capsule endoscopy, virtual colonoscopy using CT scans, fecal occult blood tests, and DNA stool tests.



  

Overall company Market Share Q1 2024

Motus Gi Holdings Inc achieved revenue growth of 14.29 % in Overall company, and improved market share, to approximately 0 %.


<<  More on MOTS Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Motus Gi Holdings Inc




Minerva Surgical Inc
Share Performance



0.00%
30 Days



Minerva Surgical Inc
Profile

Minerva Surgical Inc's business model focuses on the development and sale of innovative medical devices specifically designed for gynecological procedures.

More about Minerva Surgical Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.001 mill. $ 49.957 mill. $ -33.450 mill.


Exact Sciences Corporation
Share Performance



+2.22%
This Quarter



Exact Sciences Corporation
Profile

Exact Sciences Corporation is a medical diagnostics company that specializes in early cancer detection. Their business model involves developing and commercializing non-invasive, DNA-based tests for the detection of colorectal cancer, as well as other cancers and diseases. By leveraging advanced technology and partnerships with healthcare providers, Exact Sciences aims to improve patient outcomes through early detection and intervention.

More about Exact Sciences Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 19,599.023 mill. $ 3,245.310 mill. $ -207.949 mill.


Escalon Medical Corp
Share Performance



-11.76%
This Year



Escalon Medical Corp
Profile

Escalon Medical Corp is a medical technology company that operates through three segments: ophthalmic diagnostics, ophthalmic surgical and ambulance services. They develop, manufacture and sell a range of medical devices and provide EMS billing services to healthcare providers.

More about Escalon Medical Corp 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.177 mill. $ 11.445 mill. $ 1.613 mill.


Conmed Corporation
Share Performance



+25.54%
This Quarter



Conmed Corporation
Profile

Conmed Corporation operates as a global medical technology company that develops, manufactures, and markets surgical devices and equipment for minimally invasive procedures.

More about Conmed Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,395.170 mill. $ 1,371.657 mill. $ 56.497 mill.


Boston Scientific Corporation
Share Performance



-15.84%
30 Days



Boston Scientific Corporation
Profile

Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.

More about Boston Scientific Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 63,821.970 mill. $ 20,997.000 mill. $ 3,669.000 mill.

27 more competitors available

Sign in to see all competitors

Sources: Motus Gi Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Motus Gi Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.